Ruigong Zhu
Nanjing University of Chinese Medicine(CN)Guiyang Medical University(CN)
Publications by Year
Research Areas
Gut microbiota and health, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Immune cells in cancer, RNA modifications and cancer
Most-Cited Works
- → Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB–P300–BRD4 axis(2021)119 cited
- → FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation(2017)102 cited
- → BRD4 contributes to LPS-induced macrophage senescence and promotes progression of atherosclerosis-associated lipid uptake(2020)86 cited
- → Non-canonical STING–PERK pathway dependent epigenetic regulation of vascular endothelial dysfunction via integrating IRF3 and NF-κB in inflammatory response(2023)56 cited
- → Melatonin antagonizes ovarian aging via YTHDF2-MAPK-NF-κB pathway(2020)30 cited
- → Lactiplantibacillus plantarum ATCC8014 Alleviates Postmenopausal Hypercholesterolemia in Mice by Remodeling Intestinal Microbiota to Increase Secondary Bile Acid Excretion(2024)15 cited
- → Mitochondrial dysfunction drives cellular senescence: Molecular mechanisms of inter-organelle communication(2025)6 cited
- → BRD4 promotes LPS-induced endothelial cells senescence via activating and cooperating STING-IRF3 pathway(2024)5 cited
- → SLC22A6-dependent lactylation of H3K9 aggravates endothelial dysfunction and atherosclerosis(2025)3 cited
- → Liuwei Dihuang formula ameliorates perimenopausal atherosclerosis by modulating the microbiota-dependent TMA-TMAO metabolic axis(2025)3 cited